Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology

Fort Pierce, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced the issuance of two new United States patents covering proprietary methods and compositions designed to enhance enzymatic activity in hair follicles, further strengthening the Company's intellectual property portfolio supporting its Hair Enzyme Booster product.

Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl

Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis's over-the-counter (OTC) nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product.

Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq

FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the closing of its underwritten U.S. public offering of 1,000,000 shares of common stock at a public offering price of $4.00 per share for aggregate gross proceeds of approximately US $4,000,000, prior to deducting underwriting discounts and offering expenses (the “Offering”). The shares of common stock commenced trading on the Nasdaq Capital Markets on November 13, 2025 under the ticker symbol “CABR”.

Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq

FORT PIERCE, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the pricing of its underwritten U.S. public offering of 1,000,000 common shares at a public offering price of $4.00 per common share for aggregate gross proceeds of approximately US $4,000,000, prior to deducting underwriting discounts and offering expenses (the “Offering”).